CervoMed Financial Statements From 2010 to 2025
| CRVO Stock | 8.48 0.06 0.71% |
Gross Profit | Market Capitalization | Revenue | Earnings Share (2.90) | Quarterly Revenue Growth (0.83) |
CervoMed Total Revenue |
|
Check CervoMed financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CervoMed's main balance sheet or income statement drivers, such as Interest Expense of 0.0, Total Revenue of 10.2 M or Other Operating Expenses of 12.5 M, as well as many indicators such as Price To Sales Ratio of 1.84, Dividend Yield of 0.0 or PTB Ratio of 0.46. CervoMed financial statements analysis is a perfect complement when working with CervoMed Valuation or Volatility modules.
CervoMed | Select Account or Indicator | Build AI portfolio with CervoMed Stock |
CervoMed Balance Sheet | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CervoMed Income Statement | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CervoMed Cash Flow Statement | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Ratios | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CervoMed Valuation Data | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CervoMed Fundamental Market Drivers
CervoMed Upcoming Events
| 12th of February 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 12th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
About CervoMed Financial Statements
CervoMed investors utilize fundamental indicators, such as revenue or net income, to predict how CervoMed Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | -11.2 M | -10.6 M | |
| Total Revenue | 9.7 M | 10.2 M | |
| Cost Of Revenue | 18.8 M | 19.7 M | |
| Stock Based Compensation To Revenue | 0.14 | 0.14 | |
| Sales General And Administrative To Revenue | 0.94 | 0.89 | |
| Research And Ddevelopement To Revenue | 1.93 | 2.03 | |
| Revenue Per Share | 1.21 | 1.15 | |
| Ebit Per Revenue | (1.87) | (1.97) |
Pair Trading with CervoMed
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if CervoMed position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CervoMed will appreciate offsetting losses from the drop in the long position's value.Moving together with CervoMed Stock
Moving against CervoMed Stock
| 0.7 | DTIL | Precision BioSciences | PairCorr |
| 0.68 | VANI | Vivani Medical | PairCorr |
| 0.43 | 688578 | Shanghai Allist Phar | PairCorr |
| 0.36 | EQ | Equillium Buyout Trend | PairCorr |
| 0.34 | PYC | Physiomics Plc | PairCorr |
The ability to find closely correlated positions to CervoMed could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace CervoMed when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back CervoMed - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling CervoMed to buy it.
The correlation of CervoMed is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as CervoMed moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if CervoMed moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for CervoMed can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of CervoMed Correlation against competitors. To learn how to invest in CervoMed Stock, please use our How to Invest in CervoMed guide.You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CervoMed. If investors know CervoMed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CervoMed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.90) | Revenue Per Share | Quarterly Revenue Growth (0.83) | Return On Assets | Return On Equity |
The market value of CervoMed is measured differently than its book value, which is the value of CervoMed that is recorded on the company's balance sheet. Investors also form their own opinion of CervoMed's value that differs from its market value or its book value, called intrinsic value, which is CervoMed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CervoMed's market value can be influenced by many factors that don't directly affect CervoMed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CervoMed's value and its price as these two are different measures arrived at by different means. Investors typically determine if CervoMed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CervoMed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.